Skip to content

Renal Effects of RIPC in Patients After Total Arch Replacement

Renal Effects of Remote Ischemic Preconditioning in Patients After Total Arch Replacement

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03141385
Acronym
RenRIPC-TAR
Enrollment
130
Registered
2017-05-05
Start date
2017-04-07
Completion date
2018-05-30
Last updated
2018-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury, Dialysis

Brief summary

The purpose of this study is to test the hypothesis that remote ischemic preconditioning prevents acute kidney injury and improves clinical outcomes in patients undergoing total arch replacement.

Detailed description

Acute kidney injury (AKI) is a well-recognized complication after cardio-thoracic surgeries and is associated with increased morbidity and mortality. Total arch replacement is reported with a relatively high incidence of post-operative AKI. In addition, few effective preventive or therapeutic interventions for AKI have been identified. A number of studies have now addressed renal protection as a primary outcome following RIPC. Because the mechanism of I/R injury are similar to those proposed for AKI after CPB, the purpose of this study is to test the hypothesis that remote ischemic preconditioning prevents acute kidney injury and improves clinical outcomes in patients undergoing total arch replacement.

Interventions

OTHERremote ischemic preconditioning

Remote ischemic preconditioning (RIPC) will be induced after the general anesthesia prior to the cardiopulmonary bypass by four cycles of right limber ischemia (5-min blood pressure cuff inflation to a pressure of 200mmHg or a pressure that is 50 mmHg higher than SAP and 5-min cuff deflation)

OTHERControl

Four cycles of right upper limb pseudo ischemia and reperfusion, which will be induced by 5-minute blood pressure cuff inflation to a low pressure of 20 mmHg followed by 5-minute cuff deflated.

Sponsors

Chinese Academy of Medical Sciences, Fuwai Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* patients scheduled for total arch replacement * written informed consent

Exclusion criteria

* pre-existing AKI * peripheral vascular disease affecting the upper limbs * hybrid total arch replacement * the history of kidney transplantation

Design outcomes

Primary

MeasureTime frameDescription
Incidence of AKI within the 7 days after the surgeryWithin 7 days after the surgeryAKI defined by KDIGO criteria

Secondary

MeasureTime frameDescription
Renal replacement therapyWithin 30 days after the surgerythe requirement for RRT during index hospital stay
Mechanical ventilation durationWithin 30 days after the surgeryduration of mechanical ventilation in the intensive care unit
Length of intensive care unit stayWithin 30 days after the surgerylength of stay on the intensive care unit
Incidence of severe AKI (stage 2 and stage 3)Within 7 days after the surgeryseverity defined by KDIGO criteria
StrokeWithin 30 days after the surgerynew onset stroke during index hospital stay
ParaplegiaWithin 30 days after the surgeryimpairment in motor or sensory function of the lower extremities during index hospital stay
In-hospital deathWithin 30 days after the surgeryin-hospital all-cause death

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026